PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Larger E et al. – A major goal of treatment in patients with type 2 diabetes is to reduce vascular risk. Recent facts have changed our view : several large trials remained inconclusive, especially because the number of vascular events was lower than anticipated. It thus appears that the vascular risk has changed in diabetes, probably owing to the large prescription of statins and treatment of hypertension with strict targets. This also raises new questions about the strategy of screening for coronary disease in diabetics.


   

Today in Endocrinology...keeping you current

Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09

Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09

Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address